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Research
Many studies have examined the effects of lead 
and cadmium exposures on neuro  behavioral 
functions, such as declines in cognitive 
ability and visuomotor performance (Balbus-
Kornfeld et al. 1995; Viaene et al. 2000), but 
there is increasing evidence suggesting that 
exposures are associated with hearing loss 
and alterations in auditory evoked potentials 
(Araki et al. 1986; Forst et al. 1997; Murata 
et al. 1993; Ozcaglar et al. 2001). In addition, 
several studies have reported that workers 
with occupational exposure to lead have 
significantly poorer postural balance responses 
than do unexposed workers (Chia et al. 1994, 
1996; Dick et al. 1999; Iwata et al. 2005; Linz 
et al. 1992; Ratzon et al. 2000; Yokoyama 
et al. 1997, 2002). Impaired postural stability 
also has been associated with blood lead 
concentrations in children (Bhattacharya et al. 
1990, 1995, 2006, 2007; Després et al. 2005). 
However, relatively few studies have evaluated 
associations between cadmium exposure and 
balance disturbance (Kilburn and McKinley 
1996; Viaene et al. 2000).
An individual’s ability to maintain balance 
is an essential component for nearly all daily 
life activities. The control of balance depends 
on sensory inputs from the vestibular and visual 
systems, neural processing centers throughout 
the central nervous system, and motor outputs 
(the proprioceptive system). Functional declines 
in any of these systems can lead to balance 
deficits (Horak 2006; Sturnieks et al. 2008). 
Although the prevalence of balance dysfunction 
in the United States is unknown, data from the 
National Health and Nutrition Examination 
Survey (NHANES) suggest that 35% of 
U.S. adults ≥ 40 years of age (69 million 
people) show objective evidence of vestibular 
dysfunction (Agrawal et al. 2009).
Few studies of risk factors for decreased 
balance andvestibular function have been con-
ducted in the general population, despite the 
public health significance of these outcomes 
(Neuhauser 2007; Neuhauser et al. 2005). 
Furthermore, it is unclear whether exposures 
to lead and cadmium affect balance or ves-
tibular function in the general population. 
Therefore, we investigated the relationship 
between blood lead and cadmium levels and 
balance or vestibular dysfunction (identi-
fied based on a modified Romberg Test for 
Standing Balance on Firm and Compliant 
Support Surfaces) among adults who partici-
pated in NHANES 1999–2004.
Methods and Materials
Study population. The NHANES, conducted 
by the Centers for Disease Control and 
Prevention (CDC), is a nationally representative 
survey of the noninstitutionalized civilian popu-
lation in the United States. The 1999–2004 
NHANES study protocols were approved 
by the National Center for Health Statistics 
Institutional Review Board. All participants 
gave oral and written informed consent.
The present study used data on balance and 
blood levels of lead and cadmium that were 
measured concurrently in NHANES partici-
pants (1999–2004). The NHANES Balance 
Component was assessed in a 50% sam-
ple of U.S. adults 40–69 years of age in the 
1999–2000 survey (n = 851), and in all adult 
participants ≥ 40 years of age in the NHANES 
2001–2002 (n = 2,541) and the 2003–2004 
(n = 2,459) surveys. Of the 5,851 total partici-
pants, 5,574 (95.3% of those who were eligible) 
also had blood lead and cadmium measure-
ments and data for all covariate variables.
Balance examination. For safety reasons, 
particpants were excluded from the balance 
test if, at the time of the exam, they felt unable 
to stand on their own, had current symptoms 
of dizziness or lightheadedness, weighed more 
than 275 lb, had a waist circumference that 
did not accommodate any standard-sized safety 
gait belt, needed a leg brace to stand unas-
sisted, or had had a foot or leg amputation. 
Those who were blind or who were sufficiently 
visually impaired to require assistance in locat-
ing the exam room were also excluded.
The Romberg Test of Standing Balance on 
Firm and Compliant Support Surfaces (CDC 
2001b) measures the participant’s ability to 
maintain balance under four test conditions, 
which are ordered in increasing levels of dif-
ficulty. In brief, in test condition 1, subjects 
must maintain their balance while standing 
(with their feet together and arms folded 
across the waist, holding each elbow with the 
opposite hand) for 15 sec. In test condition 2, 
subjects must maintain their balance while 
standing for 15 sec with their eyes closed so 
that only vestibular and proprioceptive (i.e., 
leg muscle position sense) information is avail-
able. In test condition 3, subjects must main-
tain their balance while standing for 30 sec on 
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Ba c k g r o u n d: Few studies have been conducted to identify risk factors for balance and vestibular 
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by atomic absorption spectrometry. Associations were estimated using logistic regression models 
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cally challenging balance test among subjects with the highest vs. lowest quintiles of blood lead was 
1.24 (95% CI: 1.04, 1.48). Cadmium levels were not associated with time to failure.
co n c l u s i o n s: Our findings suggest that blood lead and cadmium levels may be associated with 
balance and vestibular dysfunction in a general sample of U.S. adults.
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a foam-padded surface, which reduces pro-
prio  ceptive input but does not affect visual or 
vestibular input. In test condition 4, subjects 
must maintain their balance while standing 
for 30 sec on a foam-padded surface with their 
eyes closed, so that input is available from the 
vestibular system only.
Each condition is scored on a pass or fail 
basis; failure was defined as movement of the 
feet from the initial test position; movement of 
the arms off the waist; opening the eyes during 
test conditions 2 or 4; or any intervention 
by the health technologist to stop the subject 
from falling within the maximum time period 
for the individual test. Subjects who fail a test 
condition are given one opportunity to repeat 
the test. Because each successive test condition 
from 1 to 4 is progressively more difficult than 
the condition preceding it, the balance-testing 
component is ended whenever a subject fails 
to pass a condition. The time to failure (i.e., 
loss of balance) is also recorded for test condi-
tion 4, with those who passed the test assigned 
the maximum value of 30 sec.
Measurement of blood lead and cadmium 
levels. Whole blood specimens were stored 
frozen (–20°C) until they were shipped to the 
National Center for Environmental Health for 
testing. Blood lead and cadmium levels were 
measured using a multielement atomic absorp-
tion spectrometer with Zeeman background 
correction (SIMAA 6000 model; Perkin-
Elmer, Norwalk, CT, USA). The analytical 
laboratory (Division of Laboratory Sciences, 
National Center for Environmental Health, 
Atlanta, GA, USA) followed extensive quality 
control procedures.
For external calibration of blood lead and 
cadmium levels (CDC 2001a, 2004), stan-
dard reference materials from the National 
Institute of Standards and Technology 
(NIST; Gaithersburg, MD, USA) were used. 
The limit of detection (LOD) for blood lead 
was 0.3 µg/dL in NHANES (1999–2004). 
For blood cadmium, the LOD was 0.3 µg/L 
in NHANES (1999–2002) and 0.2 µg/L in 
NHANES (2003–2004). For participants 
with blood cadmium or lead levels below the 
LOD, a level equal to the LOD divided by 
the square root of 2 was used (CDC 2005; 
Hornung and Reed 1990). Interassay coef-
ficients of variation ranged from 3.1% to 
4.0% for lead and from 3.2% to 9.4% for 
cadmium.
Other variables of interests. We also evalu-
ated other factors that might be associated 
with balance dysfunction and exposure to 
lead or cadmium, including age (40–59 years, 
60–79 years, and ≥ 80 years), sex (male and 
female), race/ethnicity (non-Hispanic white, 
non-Hispanic black, Mexican American, and 
other), and education (< high school, high 
school diploma, and > high school). Smoking 
and consumption of alcohol were modeled as 
pack-years and ounces per day, respectively 
(continuous variables, those who never smoked 
or who never used alcohol were assigned values 
of 0). History of stroke was defined based on a 
self-reported physician’s diagnosis. History 
of diabetes mellitus was defined based on a 
self-reported physician’s diagnosis or an 8-hr 
fasting serum glucose level ≥ 126 mg/dL at 
the time of the examination. Dietary cal-
cium intake was categorized as ≥ 1,000 mg or 
< 1,000 mg, and iron intake was categorized as 
≥ 8 mg or < 8 mg.
Statistical analysis. To account for the 
complex sampling design, weighted estimates 
of the population parameters were computed. 
Because of differences in the sampling frames 
for the balance examination, we combined 
Table 1. Characteristics of the NHANES 1999–2004 study populationa based on the presence or absence of balance dysfunction.
Without balance dysfunction 
(n = 3,084)
With balance dysfunctionb
Characteristic Case 1 (n = 7) Case 2 (n = 163) Case 3 (n = 86) Case 4 (n = 2,234) Total (n = 2,490)
Age (years)
40–59 2,064 (66.93) — 19 (11.66) 6 (6.98) 708 (31.69) 733 (50.18)
60–79 956 (31.00) 3 (42.86) 82 (50.31) 36 (41.86) 1,184 (53.00) 1,305 (40.56)
≥ 80 64 (2.08) 4 (57.14) 62 (38.04) 44 (51.16) 342 (15.31) 452 (9.26)
Sex
Male 1,578 (51.17) 3 (42.86) 94 (57.67) 37 (43.02) 1,104 (49.42) 1,238 (50.52)
Female 1,506 (48.83) 4 (57.14) 69 (42.33) 49 (56.98) 1,130 (50.58) 1,252 (49.48)
Race/ethnicity
White 1,687 (54.70) 3 (42.86) 109 (66.87) 56 (65.12) 1,270 (56.85) 1,438 (56.06)
Black 588 (19.07) 3 (42.86) 15 (9.20) 15 (17.44) 355 (15.89) 388 (17.51)
Hispanic 722 (23.41) 1 (14.29) 39 (23.93) 14 (16.28) 544 (24.35) 598 (23.68)
Others 87 (2.82) — — 1 (1.16) 65 (2.91) 66 (2.74)
Education
< High school 770 (24.97) 5 (71.43) 70 (42.94) 41 (47.67) 823 (36.84) 939 (30.66)
High school 710 (23.02) 2 (28.57) 41 (25.15) 17 (19.77) 569 (25.47) 629 (24.02)
≥ College 1,604 (52.01) — 52 (31.90) 28 (32.56) 842 (37.69) 922 (45.32)
History of diabetes
Yes 334 (10.83) 1 (14.29) 49 (30.06) 26 (30.23) 435 (19.47) 511 (15.16)
No 2,750 (89.17) 6 (85.71) 114 (69.94) 60 (69.77) 1,799 (80.53) 1,979 (84.84)
History of stroke
Yes 59 (1.91) — 17 (10.43) 14 (16.28) 123 (5.51) 154 (3.82)
No 3,025 (98.09) 7 (100.00) 146 (89.57) 72 (83.72) 2,111 (94.49) 2,336 (96.18)
Calcium intake (mg)
≥ 1,000 787 (25.52) 2 (28.57) 31 (19.02) 8 (9.30) 481 (21.53) 522 (23.48)
< 1,000 2,297 (74.48) 5 (71.43) 132 (80.98) 78 (90.70) 1,753 (78.47) 1,968 (76.52)
Iron intake (mg)
≥ 8 2,561 (83.04) 7 (100.00) 125 (76.69) 60 (69.77) 1,789 (80.08) 1,981 (81.49)
< 8 523 (16.96) — 38 (23.31) 26 (30.23) 445 (19.92) 509 (18.51)
Smoking (pack-years) 3.40 (2.79, 4.00) 6.0 (0.00, 17.06) 3.64 (0.16, 7.11) 1.64 (0.00, 3.87) 3.82 (3.17, 4.46) 3.76 (3.07, 4.45)
Alcohol (ounce/day) 0.44 (0.37, 0.50) — 0.38 (–0.07, 0.82) 0.17 (0.07, 0.28) 0.39 (0.33, 0.46) 0.39 (0.32, 0.46)
Blood lead (µg/dL) 2.09 (2.01, 2.18) 4.64 (2.61, 6.67) 2.46 (2,13, 2.79) 2.78 (2.31, 3.25) 2.38 (2.27, 2.48) 2.39 (2.29, 2.49)
Blood cadmium (µg/L) 0.59 (0.54, 0.63) 0.96 (0.29, 1.63) 0.67 (0.49, 0.84) 0.62 (0.48, 0.75) 0.63 (0.61, 0.66) 0.64 (0.61, 0.67)
—, no subjects.
aFor categorical variables, values are expressed as the number of participants (percentage); for continuous variables, values are the weighted mean (95% CIs). bIncludes subjects who 
failed to complete at least one test; case 1 includes subjects who failed to pass test condition 1; case 2 includes subjects who passed test condition 1 but failed to pass test condition 2; 
case 3 includes subjects who passed test conditions 1 and 2 but failed to pass test condition 3; case 4 includes subjects who passed test conditions 1, 2, and 3 but failed to pass test 
condition 4.Lead, cadmium, and vestibular dysfunction
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the 1999–2000 and 2001–2002 balance data 
sets using special 4-year balance subsample 
weights; 6-year data analyses (1999–2004) 
were performed by combining the 4-year bal-
ance subsample weights with the 2003–2004 
examination weights according to NHANES 
analytic guidelines (CDC 2006). We per-
formed all analyses using SAS 9.2 (SAS 
Institute Inc., Cary, NC, USA) and set sta-
tistical significance at α = 0.05. All statistical 
  analyses were 2-sided tests.
Statistical differences in demographic 
characteristics between participants with and 
without balance dysfunction were evaluated. 
Because of their right-skewed distribution, 
blood concentrations of lead and cadmium 
were log transformed and were catego-
rized into quintiles based on their weighted 
  distributions.
Binary logistic regression using PROC 
SURVEYLOGISTIC procedures (SAS 
Institute Inc.) was conducted to compare 
the prevalence of balance dysfunction for 
each quintile of lead or cadmium distribu-
tion with the lowest quintile of exposure. We 
used the Hosmer–Lemeshow goodness-of-fit 
test (Hosmer and Lemeshow 2000), Pearson 
residual normality plots, and their corre-
sponding histograms to assess model fit. To 
estimate odds ratios (ORs) for failure of each 
individual test condition, we conducted multi-
nomial logit regression analyses using the gen-
eralized logit function (GLOGIT) of PROC 
SURVEYLOGISTIC (SAS Institute Inc.). 
Here, because we did not have sufficient power 
to estimate associations between quintiles of 
exposure and case 1, given that only seven par-
ticipants failed, estimates for case 1 from the 
results were excluded. We calculated adjusted 
ORs and their 95% confidence intervals (CIs) 
for each logistic regression. The Taylor series 
  linearization method (Rust 1985) was used for 
complex sample   variance estimation.
We estimated associations between fail-
ure time for balance test condition 4 and 
blood lead and cadmium levels using Cox 
proportional hazards models (Cox 1972), 
with outcomes censored at 30 sec for partici-
pants who completed the test without losing 
their balance. We checked the proportional 
hazards assumption using log-negative–log 
survival curves, which were approximately par-
allel, indicating that the proportional hazards 
assumption was not violated. The Cox pro-
portional hazards model was performed by 
PROC SURVEYPHREG procedures (SAS 
Institute Inc.).
Statistical models were adjusted for age, 
sex, race/ethnicity, education, pack-years of 
smoking, alcohol consumption (ounces per 
day), histories of stroke and diabetes, and 
intakes of calcium and iron.
Results
Of the 5,574 participants, 3,084 success-
fully completed all four balance test condi-
tions and were designated as without balance 
dysfunction, whereas 2,490 failed to pass 
one of the test conditions, including 7 who 
failed to pass test condition 1 (case 1); 163 
who passed condition 1 but failed to pass test 
condition 2 (case 2); 86 who passed condi-
tions 1 and 2 but failed to pass test condition 3 
(case 3); and 2,234 who passed conditions 1, 
2, and 3 but failed to pass test condition 4 
(case 4) (Table 1). Compared with partici-
pants who displayed no balance dysfunction, 
those with a balance dysfunction were older 
(54 years vs. 65 years). Participants with less 
education, the presence of diabetes and stroke, 
and low calcium and iron intakes were more 
likely to display balance dysfunction. There 
were no statistically significant differences in 
sex, race/ethnicity, smoking pack-years, or 
average daily alcohol consumption between the 
two groups. The means (95% CI) of the blood 
lead and cadmium levels were 2.21 µg/dL   
(95% CI: 2.13, 2.28) and 0.61 µg/L (95% CI: 
0.58, 0.64), respectively. Participants with ver-
sus those without vestibular dysfunction had 
higher mean blood lead (2.39 µg/dL, 95% CI: 
2.29, 2.49 vs. 2.09 µg/dL, 95% CI: 2.01, 2.18) 
and cadmium (0.64 µg/L, 95% CI: 0.61, 0.67 
vs. 0.59 µg/L, 95% CI: 0.54, 0.63) levels.
Fully adjusted ORs for balance dysfunc-
tion, comparing blood lead quintiles 2, 3, 
4, and 5 with the lowest quintile, were 1.14 
(95% CI: 0.94, 1.38), 0.96 (95% CI: 0.74, 
1.24), 1.18 (95% CI: 0.95, 1.47), and 1.42 
(95% CI: 1.07, 1.89), respectively, (Table 2). 
Corresponding ORs for blood cadmium 
were 1.27 (95% CI: 1.03, 1.56), 0.97 (95% 
CI: 0.83, 1.15), 1.28 (95% CI: 1.01, 1.61), 
and 1.27 (95% CI: 1.01, 1.60), respectively. 
Pearson residual normality plots and corre-
sponding histograms, as well as Hosmer and 
Lemeshow goodness-of-fit tests (p = 0.69 for 
lead and p = 0.47 for cadmium) indicated that 
models fit reasonably well (data not shown).
Fully adjusted ORs for failure of each bal-
ance test comparing the highest with the low-
est quintiles of blood lead concentrations were 
1.38 (95% CI: 0.64, 2.94) for case 2, 2.17 
(95% CI: 1.03, 4.59) for case 3, and 1.42 
(95% CI: 1.07, 1.87) for case 4 (Table 3). The 
corresponding ORs for cadmium were 1.22 
(95% CI: 0.55, 2.70) for case 2, 1.83 (95% 
CI: 0.61, 5.49) for case 3, and 1.27 (95% CI: 
1.01, 1.61) for case 4.
Time to failure for balance test 4 was sig-
nificantly higher among participants with the 
highest versus lowest quintile of lead exposure 
(hazard ratio = 1.24, 95% CI: 1.04, 1.48), but 
cadmium levels were not significantly associ-
ated with time to failure (Table 4).
Table 2. ORsa of balance dysfunction by quintile of 
blood lead and cadmium levels.
Quintile
With/without 
balance 
dysfunction OR (95% CIs)
Lead (µg/dL)
1 (< 1.2) 440 696 1 (Reference)
2 (1.3–1.7) 501 684 1.14 (0.94, 1.38)
3 (1.8–2.2) 414 561 0.96 (0.74, 1.24)
4 (2.3–3.2) 542 607 1.18 (0.95, 1.47)
5 (3.3–48) 593 536 1.42 (1.07, 1.89)
Cadmium (µg/L)
1 (< 0.2) 440 696 1 (Reference)
2 (0.3–0.3) 501 684 1.27 (1.03, 1.56)
3 (0.4–0.5) 414 561 0.97 (0.83, 1.15)
4 (0.6–0.8) 542 607 1.28 (1.01, 1.61)
5 (0.9–7.4) 593 536 1.27 (1.01, 1.60)
aOR is the ratio of the odds of balance dysfunction for total 
participants who failed to complete at least one test (i.e., 
those with balance dysfunction, including all participants 
of cases 1, 2, 3, and 4, to the odds of balance dysfunc-
tion for those who passed all four stages of the balance 
test). The model was adjusted for age, sex, race/ethnicity, 
education, history of diabetes, history of stroke, smoking, 
alcohol consumption, calcium intake, and iron intake.
Table 3. ORs of the failure or success of each test of balance dysfunction on increasing quintiles of blood 
lead and cadmium levels.
Case 2 (n = 163) Case 3 (n = 86) Case 4 (n = 2,234)
Quintile
No. of 
subjects OR (95% CIs)
No. of 
subjects OR (95% CIs)
No. of 
subjects OR (95% CIs)
Lead (µg/dL)
1 (< 0.2) 27 Reference 13 Reference 400 Reference
2 (1.3–1.7) 32 1.68 (0.84, 3.38) 16 1.64 (0.74, 3.62) 452 1.11 (0.93, 1.34)
3 (1.8–2.2) 21 0.48 (0.20, 1.19) 12 1.09 (0.53, 2.27) 379 0.97 (0.76, 1.26)
4 (2.3–3.2) 35 0.95 (0.45, 2.05) 22 2.15 (1.01, 4.60) 485 1.19 (0.96, 1.47)
5 (3.3–48) 48 1.38 (0.64, 2.94) 23 2.17 (1.03, 4.59) 518 1.42 (1.07, 1.87)
Cadmium (µg/L)
1 (< 0.2) 24 Reference 6 Reference 323 Reference
2 (0.3–0.3) 19 1.39 (0.81, 2.38) 17 4.33 (1.35, 13.83) 300 1.24 (0.99, 1.55)
3 (0.4–0.5) 62 1.33 (0.70, 2.53) 24 1.45 (0.56, 3.74) 716 0.96 (0.81, 1.13)
4 (0.6–0.8) 30 0.83 (0.39, 1.76) 21 3.01 (1.24, 7.33) 451 1.29 (1.01, 1.63)
5 (0.9–7.4) 28 1.22 (0.55, 2.70) 18 1.83 (0.61, 5.49) 444 1.27 (1.01, 1.61)
Number of subjects includes those participants with balance dysfunction who failed to complete at least one test; case 2 
includes subjects who passed test condition 1 but failed to pass test condition 2; case 3 includes subjects who passed 
test conditions 1 and 2 but failed to pass test condition 3; case 4 includes subjects who passed test conditions 1, 2, and 
3 but failed to pass test condition 4. The model was adjusted for age, sex, race/ethnicity, education, history of diabetes, 
history of stroke, smoking, alcohol consumption, calcium intake, and iron intake. No. subjects: number of subjects with 
balance dysfunction.Min et al.
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Discussion
After adjusting for potential covariates, the 
prevalence of balance dysfunction was sig-
nificantly higher among participants in the 
highest versus lowest quintiles of lead and 
cadmium (OR = 1.42, 95% CI: 1.07, 1.89 
and OR = 1.27, 95% CI: 1.01, 1.60, respec-
tively). However, lower quintiles of lead were 
not clearly associated with the outcome, and 
associations with cadmium were comparable 
for quintiles 2, 4, and 5, but absent for quin-
tile 3. The hazard ratio for time to failure for 
balance test 4 was significantly higher among 
participants in the highest versus lowest quin-
tiles of blood lead (hazard ratio = 1.24, 95% 
CI: 1.04, 1.48) only, while cadmium levels 
were not clearly associated with time to failure 
for test condition 4.
There is substantial evidence that impli-
cates associations of impaired balance 
(Bhattacharya et al. 1990, 1995, 2006, 2007; 
Chia et al. 1994, 1996; Després et al. 2005; 
Dick et al. 1999; Iwata et al. 2005; Kilburn 
and McKinley 1996; Linz et al. 1992; Ratzon 
et al. 2000; Viaene et al. 2000; Yokoyama 
et al. 1997, 2002), hearing loss (Agirdir et al. 
2002; Bertoni and Sprenkle 1988; Bleecker 
et al. 2003; de Abreu and Suzuki 2002; Forst 
et al. 1997; Hwang et al. 2009; Lasky et al. 
2001; Ozcaglar et al. 2001; Yokoyama et al. 
2002), and alterations in auditory evoked 
potential (Araki et al. 1986; Bleecker et al. 
2003; Murata et al. 1993) with exposure to 
lead and cadmium. However, it is not known 
whether exposure to lead and cadmium 
induces vestibular dysfunction specifically.
To our knowledge, we are the first to 
demon  strate associations between impaired 
vestibular function and exposure to lead and 
cadmium in the general population. However, 
the clinical relevance of the outcomes we 
assessed is uncertain and it is not clear whether 
the balance test used reflects a defect in vestibu-
lar function specifically. Because postural bal-
ance is controlled by a complex interaction of 
multiple sensori  motor processes (i.e., the visual 
system, proprioception, and the vestibular sys-
tem), balance, even with the limited input, can 
be maintained with the remaining afferents 
(Horak 2006). For example, test condition 4 
was conducted on a foam-padded surface to 
reduce proprioception information; proprio-
ception is still present but may be inaccurate, 
and the importance of the proprioceptive sys-
tem to balance increases when visual informa-
tion is also removed (Sahlstrand et al. 1978).
Our study has several limitations. First, 
because of its cross-sectional design, we can not 
confirm the temporal sequence of exposures 
and outcomes. However, it is unlikely that 
balance and vestibular dysfunction increases 
an individual’s exposure to lead and cadmium. 
Second, blood lead and cadmium levels alone 
are not an accurate reflection of lifetime expo-
sures. Although blood measurements of both 
metals are commonly used in studies, and 
some studies have suggested that the effects of 
lead on postural stability or vestibular function 
are related more to recent increases in blood 
lead concentrations among exposed workers 
rather than to cumulative body burdens (Chia 
et al. 1996; Yokoyama et al. 1997), studies 
using markers that reflect cumulative expo-
sure are needed. Third, we defined vestibular 
dysfunction based on the Romberg Test of 
Standing Balance, which is not a sensitive tool 
for diagnosing clinically relevant vestibular dys-
function. However, the test is commonly used 
as a standardized screening instrument in bal-
ance assessments in both clinical and research 
settings, and test results are considered when 
diagnosing vestibular dysfunction in clinical 
settings (Dobie 1997). Fourth, we could not 
control for exposure to cadmium and lead in 
the same model because of multicollinearity, 
and therefore could not estimate indepen-
dent effects of lead and cadmium on balance/
vestibular function. Finally, misclassification 
of self-reported data or possible bias due to 
uncontrolled confounding by unmeasured fac-
tors, such as family history and urbanization, 
cannot be ruled out.
In conclusion, we provide preliminary evi-
dence of associations between blood levels of 
lead and cadmium and balance and vestibular 
dysfunction in a representative sample of U.S. 
adults ≥ 40 years of age. Although our findings 
require confirmation, they suggest that back-
ground exposures to lead and cadmium may be 
deleterious to the maintenance of balance and 
may be involved in the pathogenesis of vestibu-
lar dysfunction in the general population.
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